HPV16-E7 Expression Causes Fluorodeoxyuridine-mediated Radiosensitization in SW620 Human Colon Cancer Cells

This publication has 30 references indexed in Scilit:

• THE GENETIC DEFECT IN ATAXIA-TELANGIECTASIA
  Annual Review of Immunology, 1997
• Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression
  International Journal of Radiation Biology, 1996
• The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents
  International Journal of Cancer, 1995
• Complete Restoration of Activity to Inactive Mutants of Escherichia coli Thymidylate Synthase: Evidence that E. coli Thymidylate Synthase is a Half-the-Sites Activity Enzyme
  Biochemistry, 1995
• Dependence of Fluorodeoxyuridine-mediated Radiosensitization on S Phase Progression
  International Journal of Radiation Biology, 1995
• Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.
  Proceedings of the National Academy of Sciences, 1994
• The use of biphasic linear ramped pulsed field gel electrophoresis to quantify dna damage based on fragment size distribution
  International Journal of Radiation Oncology*Biology*Physics, 1993
• Association of human cyclin E with a periodic G1-S phase protein kinase
  Science, 1992
• Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): Critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram
  Cytometry, 1989
• Variability of thymidylate synthase activity in whole blood cultures treated with FUdR
  American Journal of Medical Genetics, 1986